Cerebral angiography with Iopamidol, a nonionic water-soluble contrast medium: Double-blind study

M. Leonardi, G. Fabris, T. Penco

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The brain vasculature was explored by carotid arteriography in a total of 40 patients. Of these, 20 were examined with a nonionic contrast medium (Iopamidol 300), and the other 20 were examined with an established product (Uromiro 300). The study, conducted in double-blind fashion, showed that while the two products compared closely in terms of opacifying power, the nonionic compound, Iopamidol, was more readily tolerated subjectively and hence was conducive to better patient cooperation during angiography. This improved tolerability of the nonionic agent is attributed to the lower osmolarity of its solution compared to the conventional salified (ionic) product.

Original languageEnglish
Pages (from-to)47-54
Number of pages8
JournalRays - International Journal of Radiological Sciences
Volume6
Issue numberSuppl. 2
Publication statusPublished - 1981

Fingerprint

Iopamidol
Cerebral Angiography
Double-Blind Method
Contrast Media
Iodamide
Angiography
Water
Patient Compliance
Osmolar Concentration
Brain
Power (Psychology)

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Cerebral angiography with Iopamidol, a nonionic water-soluble contrast medium : Double-blind study. / Leonardi, M.; Fabris, G.; Penco, T.

In: Rays - International Journal of Radiological Sciences, Vol. 6, No. Suppl. 2, 1981, p. 47-54.

Research output: Contribution to journalArticle

@article{c029ab70276f4c8c824e6f4d523eeecb,
title = "Cerebral angiography with Iopamidol, a nonionic water-soluble contrast medium: Double-blind study",
abstract = "The brain vasculature was explored by carotid arteriography in a total of 40 patients. Of these, 20 were examined with a nonionic contrast medium (Iopamidol 300), and the other 20 were examined with an established product (Uromiro 300). The study, conducted in double-blind fashion, showed that while the two products compared closely in terms of opacifying power, the nonionic compound, Iopamidol, was more readily tolerated subjectively and hence was conducive to better patient cooperation during angiography. This improved tolerability of the nonionic agent is attributed to the lower osmolarity of its solution compared to the conventional salified (ionic) product.",
author = "M. Leonardi and G. Fabris and T. Penco",
year = "1981",
language = "English",
volume = "6",
pages = "47--54",
journal = "Rays - International Journal of Radiological Sciences",
issn = "0390-7740",
publisher = "Centro Minerva Medica",
number = "Suppl. 2",

}

TY - JOUR

T1 - Cerebral angiography with Iopamidol, a nonionic water-soluble contrast medium

T2 - Double-blind study

AU - Leonardi, M.

AU - Fabris, G.

AU - Penco, T.

PY - 1981

Y1 - 1981

N2 - The brain vasculature was explored by carotid arteriography in a total of 40 patients. Of these, 20 were examined with a nonionic contrast medium (Iopamidol 300), and the other 20 were examined with an established product (Uromiro 300). The study, conducted in double-blind fashion, showed that while the two products compared closely in terms of opacifying power, the nonionic compound, Iopamidol, was more readily tolerated subjectively and hence was conducive to better patient cooperation during angiography. This improved tolerability of the nonionic agent is attributed to the lower osmolarity of its solution compared to the conventional salified (ionic) product.

AB - The brain vasculature was explored by carotid arteriography in a total of 40 patients. Of these, 20 were examined with a nonionic contrast medium (Iopamidol 300), and the other 20 were examined with an established product (Uromiro 300). The study, conducted in double-blind fashion, showed that while the two products compared closely in terms of opacifying power, the nonionic compound, Iopamidol, was more readily tolerated subjectively and hence was conducive to better patient cooperation during angiography. This improved tolerability of the nonionic agent is attributed to the lower osmolarity of its solution compared to the conventional salified (ionic) product.

UR - http://www.scopus.com/inward/record.url?scp=0019867004&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019867004&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0019867004

VL - 6

SP - 47

EP - 54

JO - Rays - International Journal of Radiological Sciences

JF - Rays - International Journal of Radiological Sciences

SN - 0390-7740

IS - Suppl. 2

ER -